Minerva Neurosciences ($NERV) is a clinical-stage biopharmaceutical company focused on the development and commercialization of a portfolio of product candidates to treat patients suffering
The complete calendar is at IPOpremium.com Ranked in size of IPO (1) Based in Memphis, TN, ServiceMaster Global Holdings ($SERV) scheduled a $700 million IPO on the NYSE with a market
Company chart and information is provided by TradingView based on 15-minute-delayed data.
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. The company primarily focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. Targeted disorders include schizophrenia, insomnia, major depressive disorder and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and major depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.
| Website: | www.minervaneurosciences.com |
| Email: | wboni@minervaneurosciences.com |
| Main Phone: | +1 617 600-7373 |
| Address: | 1601 Trapelo Road |
| Address 2: | Suite 286 |
| State: | MA |
| City / Town: | Waltham |
| Country: | US |
| Postal Code: | 02451 |
| Exchange: | NSD |
| CEO: | Remy Luthringer |
| Employees: | 14 |
| NAICS: | Pharmaceutical Preparation Manufacturing(325412) |
Minerva Neurosciences ($NERV) is a clinical-stage biopharmaceutical company focused on the development and commercialization of a portfolio of product candidates to treat patients suffering
The complete calendar is at IPOpremium.com Ranked in size of IPO (1) Based in Memphis, TN, ServiceMaster Global Holdings ($SERV) scheduled a $700 million IPO on the NYSE with a market
| Last Price N/A | Change $ N/A | Change % N/A | Tick N/A |
| Bid N/A | Bid Size N/A | Ask N/A | Ask Size N/A |
| Open N/A | High N/A | Low N/A | Prev Close N/A |
| Last Trade | Volume N/A | 52 Wk Hi N/A | 52 Wk Low N/A |
| Market Cap N/A | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares N/A | EPS (TTM) N/A | PE Ratio N/A | Exchange N/A |
© 2022 Equities News | Equities.com, Inc.
* All dates and time are being displayed in Eastern Standard Time (EST).
